经颅磁刺激联合康复训练对孤独症患儿的疗效研究

注册号:

Registration number:

ChiCTR2500109444 

最近更新日期:

Date of Last Refreshed on:

2025-09-18 11:17:55 

注册时间:

Date of Registration:

2025-09-18 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

经颅磁刺激联合康复训练对孤独症患儿的疗效研究

Public title:

Efficacy of Combined Transcranial Magnetic Stimulation and Rehabilitation Training in Children with Autism Spectrum Disorder

注册题目简写:

English Acronym:

研究课题的正式科学名称:

经颅磁刺激联合康复训练对孤独症患儿疗效研究

Scientific title:

Efficacy of Combined Transcranial Magnetic Stimulation and Rehabilitation Training in Children with Autism Spectrum Disorder

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

李竹 

研究负责人:

李竹 

Applicant:

Zhu Li 

Study leader:

Zhu Li 

申请注册联系人电话:

Applicant telephone:

+86 166 0852 0209

研究负责人电话:

Study leader's
telephone:

+86 166 0852 0209

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

476231217@qq.com

研究负责人电子邮件:

Study leader's E-mail:

476231217@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

贵州省遵义市汇川区凤凰北路98号

研究负责人通讯地址:

贵州省遵义市汇川区凤凰北路98号

Applicant address:

98 Fenghuang North Road, Huichuan District, Zunyi City, Guizhou Province

Study leader's address:

98 Fenghuang North Road, Huichuan District, Zunyi City, Guizhou Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

遵义市第一人民医院

Applicant's institution:

The First People's Hospital of Zunyi

研究负责人所在单位:

遵义市第一人民医院

Affiliation of the Leader:

The First People's Hospital of Zunyi

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

伦审(2025)1-670号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

遵义市第一人民医院医学伦理管理委员

Name of the ethic committee:

The Medical Ethics Committee of Zunyi First People's Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2025-08-20 00:00:00

伦理委员会联系人:

谢建雷

Contact Name of the ethic committee:

Jianlei Xie

伦理委员会联系地址:

贵州省遵义市汇川区凤凰北路98号

Contact Address of the ethic committee:

98 Fenghuang North Road, Huichuan District, Zunyi City, Guizhou Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 851 2311 0546

伦理委员会联系人邮箱:

Contact email of the ethic committee:

836065323@qq.com

研究实施负责(组长)单位:

遵义市第一人民医院

Primary sponsor:

The First People's Hospital of Zunyi

研究实施负责(组长)单位地址:

贵州省遵义市汇川区凤凰北路98号

Primary sponsor's address:

98 Fenghuang North Road, Huichuan District, Zunyi City, Guizhou Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

贵州省

市(区县):

Country:

China

Province:

Guizhou Province

City:

单位(医院):

遵义市第一人民医院

具体地址:

贵州省遵义市汇川区凤凰北路98号

Institution
hospital:

The First People's Hospital of Zunyi

Address:

98 Fenghuang North Road, Huichuan District, Zunyi City, Guizhou Province

经费或物资来源:

遵义市科技计划项目

Source(s) of funding:

Zunyi Science and Technology Program Fund

研究疾病:

孤独症谱系障碍  

Target disease:

Autism Spectrum Disorder

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本研究采用随机对照试验设计,旨在系统评估重复经颅磁刺激联合康复训练对孤独症患儿核心症状的临床疗效,为该法在儿童孤独症临床实践中的应用提供循证医学证据。  

Objectives of Study:

Utilizing a randomized controlled trial (RCT) design, this study aims to assess the clinical efficacy of combined repetitive Transcranial Magnetic Stimulation (rTMS) and rehabilitation training for core symptoms in children with autism spectrum disorder (ASD), thereby providing high-level evidence to inform its clinical application.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

(1)年龄>14岁者;(2)有经颅磁刺激治疗禁忌症;(3)排除一些遗传代谢进行性疾病引起的精神行为异常疾病;(4)排除听神经损伤以及构音器官异常导致语言发育障碍。

Exclusion criteria:

1.Age >14 years old; 2. There are contraindications for transcranial magnetic stimulation therapy; 3. Presence of psychiatric or behavioral abnormalities caused by progressive genetic or metabolic disorders; 4. Presence of language developmental disorders attributable to auditory nerve damage or structural abnormalities of the speech organs.

研究实施时间:

Study execute time:

From 2025-10-01 00:00:00 To 2027-09-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-10-01 00:00:00 To 2027-09-30 00:00:00

干预措施:

Interventions:

组别:

康复治疗对照组

样本量:

65

Group:

Rehabilitation treatment control group

Sample size:

干预措施:

常规康复治疗

干预措施代码:

Intervention:

Conventional rehabilitation treatment

Intervention code:

组别:

rTMS治疗组

样本量:

65

Group:

rTMS treatment group

Sample size:

干预措施:

重复经颅磁刺激+常规康复

干预措施代码:

Intervention:

repetitive transcranial magnetic stimulation + conventional rehabilitation

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

贵州省 

市(区县):

 

Country:

China

Province:

Guizhou Province

City:

单位(医院):

遵义市第一人民医院 

单位级别:

三级甲等 

Institution
hospital:

The First People's Hospital of Zunyi

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

儿童孤独症评定量表(CARS)

指标类型:

主要指标

Outcome:

Score of Childhood Autism Rating Scale (CARS)

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

儿童孤独症行为量表(ABC量)

指标类型:

次要指标

Outcome:

Score of autism behavior checklis (ABC)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

孤独症疗效评估量表(ATEC)

指标类型:

次要指标

Outcome:

Score of autism treatment evaluation checklist (ATEC)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Gesell儿童发育量表或韦氏智力测试

指标类型:

次要指标

Outcome:

development quotient

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

头部MRI特征

指标类型:

次要指标

Outcome:

Head MRI characteristics

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

脑电图数据

指标类型:

次要指标

Outcome:

Electroencephalogram detection data

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

脑干听觉诱发电位

指标类型:

次要指标

Outcome:

brainstem auditory evoked potentials

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

none

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age 14 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数字表

Randomization Procedure (please state who generates the random number sequence and by what method):

random number table

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

对患者设盲。实施研究者、疗效评价者、统计分析者三分离。

Blinding:

Blinding: Patients were blinded. Separation: The roles of treatment implementers, efficacy evaluators, and data statisticians were independent.

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2027年-2028年;按发表期刊要求共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

2027-2028; Share according to the requirements of the published journal

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2025-09-18 11:16:52